Search Results

Filter
  • 1-10 of  365 results for ""Chemokine CCL5""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis.

  • Authors : Amerzhanova Y; Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Nur-Sultan, Kazakhstan.; Vangelista L

Subjects: Models, Molecular*; CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/CCR5 Receptor Antagonists/*pharmacology ; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*chemistry

  • Source: Frontiers in immunology [Front Immunol] 2022 Jan 19; Vol. 13, pp. 826418. Date of Electronic Publication: 2022 Jan 19 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

O-GalNAcylation of RANTES Improves Its Properties as a Human Immunodeficiency Virus Type 1 Entry Inhibitor.

  • Authors : Guan X; Department of Chemistry and Biochemistry and BioFrontiers Institute, University of Colorado , Boulder, Colorado 80303, United States.; Chaffey PK

Subjects: Protein Processing, Post-Translational*; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*chemistry ; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*pharmacology

  • Source: Biochemistry [Biochemistry] 2018 Jan 09; Vol. 57 (1), pp. 136-148. Date of Electronic Publication: 2017 Dec 14.Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370623 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.

  • Authors : Zheng Y; University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA 92093, USA.; Han GW

Subjects: Models, Molecular* ; Molecular Mimicry*; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*chemistry

  • Source: Immunity [Immunity] 2017 Jun 20; Vol. 46 (6), pp. 1005-1017.e5.Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180

Record details

×
Academic Journal

HIV-1-Induced miR-146a Attenuates Monocyte Migration by Targeting CCL5 in Human Primary Macrophages.

  • Authors : Huang Q; 1 State Key Laboratory of Virology/Institute of Medical Virology/Hubei Province Key Laboratory of Allergy and Immunology, School of Basic Medical Sciences, Wuhan University , Wuhan, People's Republic of China .; Chen L

Subjects: Cell Movement*; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*biosynthesis ; HIV Infections/HIV Infections/HIV Infections/*pathology

  • Source: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2018 Jul; Vol. 34 (7), pp. 580-589. Date of Electronic Publication: 2018 May 30.Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8709376 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers.

  • Authors : Secchi M; Protein Engineering and Therapeutics Group, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, 20132, Milan, Italy.; Grampa V

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology ; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*genetics ; HIV-1/HIV-1/HIV-1/*drug effects

  • Source: Scientific reports [Sci Rep] 2018 Jan 30; Vol. 8 (1), pp. 1890. Date of Electronic Publication: 2018 Jan 30.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine.

  • Authors : Petit N; 1 Sorbonne Universités , UPMC Univ Paris 06, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI), F-75013, Paris, France .; Dorgham K

Subjects: Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*genetics ; Genetic Vectors/Genetic Vectors/Genetic Vectors/*metabolism ; HIV-1/HIV-1/HIV-1/*physiology

  • Source: Human gene therapy methods [Hum Gene Ther Methods] 2014 Aug; Vol. 25 (4), pp. 232-40.Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 101573202 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors.

  • Authors : Liu X; Division of Pharmacology and Toxicology, School of Pharmacy.; Shah A

Subjects: CCAAT-Enhancer-Binding Proteins/CCAAT-Enhancer-Binding Proteins/CCAAT-Enhancer-Binding Proteins/*genetics ; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*genetics ; HIV Infections/HIV Infections/HIV Infections/*genetics

  • Source: Scientific reports [Sci Rep] 2014 Mar 24; Vol. 4, pp. 4450. Date of Electronic Publication: 2014 Mar 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Multifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc.

  • Authors : Lobritz MA; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio, USA.; Ratcliff AN

Subjects: CCR5 Receptor Antagonists* ; Drug Resistance, Viral*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2013 Jun; Vol. 57 (6), pp. 2640-50. Date of Electronic Publication: 2013 Mar 25.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.

  • Authors : Secchi M; Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Via Olgettina 58, Milan 20132, Italy.; Longhi R

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*chemistry ; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*pharmacology ; Chemokine CCL5/Chemokine CCL5/Chemokine CCL5/*chemistry

  • Source: Chemistry & biology [Chem Biol] 2012 Dec 21; Vol. 19 (12), pp. 1579-88.Publisher: Elsevier Country of Publication: United States NLM ID: 9500160 Publication Model: Print Cited Medium: Internet ISSN: 1879-1301

Record details

×
Academic Journal

HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.

  • Authors : Nookala AR; Division of Pharmacology and Toxicology, UMKC-School of Pharmacy, Kansas City, Missouri, United States of America.; Shah A

Subjects: MAP Kinase Signaling System*; Astrocytes/Astrocytes/Astrocytes/*metabolism ; CCAAT-Enhancer-Binding Proteins/CCAAT-Enhancer-Binding Proteins/CCAAT-Enhancer-Binding Proteins/*metabolism

  • Source: PloS one [PLoS One] 2013 Nov 11; Vol. 8 (11), pp. e78855. Date of Electronic Publication: 2013 Nov 11 (Print Publication: 2013).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  365 results for ""Chemokine CCL5""